Prognostic indicators in hormone refractory prostate cancer.
Publication
, Journal Article
George, DJ; Kantoff, PW
Published in: Urol Clin North Am
May 1999
Prognostic factors in hormone refractory prostate cancer currently are of limited use to clinicians. Although studies have identified several factors that predict for poor survival in patients, most are either retrospective, or nonrandomized. Therefore, large prospective, randomized trials are needed to validate the significance of these factors. In addition, these indicators are largely descriptive of the patients' condition or the extent of disease. As more treatment options are developed for these patients, functionally relevant and prognostic molecular markers are needed to direct their care.
Duke Scholars
Published In
Urol Clin North Am
DOI
ISSN
0094-0143
Publication Date
May 1999
Volume
26
Issue
2
Start / End Page
303 / viii
Location
United States
Related Subject Headings
- Urology & Nephrology
- Survival Rate
- Risk Factors
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Proportional Hazards Models
- Prognosis
- Male
- L-Lactate Dehydrogenase
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
George, D. J., & Kantoff, P. W. (1999). Prognostic indicators in hormone refractory prostate cancer. Urol Clin North Am, 26(2), 303–viii. https://doi.org/10.1016/s0094-0143(05)70070-7
George, D. J., and P. W. Kantoff. “Prognostic indicators in hormone refractory prostate cancer.” Urol Clin North Am 26, no. 2 (May 1999): 303–viii. https://doi.org/10.1016/s0094-0143(05)70070-7.
George DJ, Kantoff PW. Prognostic indicators in hormone refractory prostate cancer. Urol Clin North Am. 1999 May;26(2):303–viii.
George, D. J., and P. W. Kantoff. “Prognostic indicators in hormone refractory prostate cancer.” Urol Clin North Am, vol. 26, no. 2, May 1999, pp. 303–viii. Pubmed, doi:10.1016/s0094-0143(05)70070-7.
George DJ, Kantoff PW. Prognostic indicators in hormone refractory prostate cancer. Urol Clin North Am. 1999 May;26(2):303–viii.
Published In
Urol Clin North Am
DOI
ISSN
0094-0143
Publication Date
May 1999
Volume
26
Issue
2
Start / End Page
303 / viii
Location
United States
Related Subject Headings
- Urology & Nephrology
- Survival Rate
- Risk Factors
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Proportional Hazards Models
- Prognosis
- Male
- L-Lactate Dehydrogenase
- Humans